Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion

Acta Haematol. 2011;126(4):214-5. doi: 10.1159/000330956. Epub 2011 Sep 16.

Authors

Stephen E Langabeer¹, Karl Haslam, Johanna Kelly, Maeve Leahy, Elisabeth Vandenberghe

Affiliation

¹ Cancer Molecular Diagnostics, Central Pathology Laboratory, St. James’s Hospital, Dublin 8, Ireland. slangabeer@stjames.ie

PMID: 21934295
DOI: 10.1159/000330956

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Exons
Fatal Outcome
Female
Fusion Proteins, bcr-abl / genetics
Fusion Proteins, bcr-abl / metabolism*
Humans
Middle Aged
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / physiopathology
Translocation, Genetic

Substances

Antineoplastic Agents
Fusion Proteins, bcr-abl